Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

HIV infection and lung cancer have little in common from a disease perspective, but the stigma that surrounds both can ...

Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops ...

FOSTER CITY, Calif., March 12, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment ...

Gilead Sciences, Inc., a biopharmaceutical company ... The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences: GILD is a dominant player ... for its treatment and grab a formidable market share. Based in Foster City, CA, its efforts to bolster its oncology and virology franchises through ...

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to the drug company Gilead Sciences (GILD) . I found the stock by using Barchart ...

NEW YORK (Reuters) -Gilead Sciences set aside $200 million for ... drugmaker's promotional speakers program for HIV drugs. The Foster City, California-based company disclosed the potential ...

University of California at San Diego, La Jolla, CA, USA. (2) Division of Gastroenterology ... (6) Texas Liver Institute, UT Health San Antonio, Texas, USA. (7) Gilead Sciences, Foster City, ...

The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Across the recent three months, 14 analysts have shared their insights on Gilead Sciences GILD, expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...